Salinomycin: a new cancer drug candidate
- PMID: 22145602
- DOI: 10.1111/j.1747-0285.2011.01287.x
Salinomycin: a new cancer drug candidate
Abstract
Very recently, it has been shown that it is possible to selectively kill breast cancer stem cells using the ionophore antibiotic, salinomycin. Its ability to kill cancer stem cells and apoptosis-resistant cancer cells may define salinomycin as a novel anticancer drug.
© 2011 John Wiley & Sons A/S.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources